The concept of influence curve, as introduced by \textit{F. R. Hampel} [J. Am. Stat. Assoc. 69, 383-393 (1974; Zbl 0305.62031)], is applied and specified for ED 50 in quantal bioassay. These curves are derived for L-, M-, and R-estimators, especially for \(\alpha\)-trimmed Spearman-Kärber estimators. Their properties are demonstrated, their robustness is defined, and some examples are given.
Recommendations
- A Note on Nonparametric Estimation of the Effective Dose in Quantal Bioassay
- Linear Bayes estimators of the potency curve in bioassay
- A Growth-Curve Model Approach to Multivariate Quantal Bioassay
- On the estimation of the influence curve
- A finite sample comparison of nonparametric estimates of the effective dose in quantal bioassay
- An Exact Confidence Interval for the Relative Potency Estimated from a Multivariate Bioassay
- Sigmoidally Constrained Maximum Likelihood Estimation in Quantal Bioassay
Cites work
- scientific article; zbMATH DE number 3386716 (Why is no real title available?)
- scientific article; zbMATH DE number 3390139 (Why is no real title available?)
- Robust estimators for quantal bioassay
- Robust Statistics
- Some Properties of the Spearman Estimator in Bioassay
- The Influence Curve and Its Role in Robust Estimation
This page was built for publication: On the influence curve for quantal bioassay
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q796242)